ABSTRACT
Pulmonary arterial hypertension may mask underlying atrial septal defects by reducing left‐to‐right shunt flow through elevated pulmonary vascular resistance and impaired right ventricular compliance. Targeted therapy may unmask latent defects, emphasizing early multimodality imaging and sustained clinical suspicion for congenital shunts when invasive hemodynamic assessment suggests shunting despite inconclusive echocardiography.
Keywords: atrial septal defect, hemodynamic unmasking, multimodality cardiac imaging, pulmonary arterial hypertension, right ventricular compliance
Dear Editor,
We read with great interest the recently published case report titled “A Case of Atrial Septal Defect Unveiled by the Treatment for Pulmonary Arterial Hypertension” [1], which describes a 51‐year‐old woman with severe pulmonary arterial hypertension in whom a previously undetected secundum atrial septal defect became hemodynamically apparent following targeted pulmonary arterial hypertension therapy, allowing subsequent transcatheter closure using a treat‐and‐repair strategy.
The central message of the report—that elevated pulmonary vascular resistance (PVR) and impaired right ventricular (RV) compliance can attenuate left‐to‐right shunt flow across an ASD, thereby masking its echocardiographic detectability—is physiologically sound and consistent with established principles of interatrial shunt dynamics [2, 3]. In the described patient, severe precapillary pulmonary hypertension with a PVR of 7.4 Wood units was associated with RV pressure overload, interventricular septal flattening, and moderate tricuspid regurgitation, all of which could reasonably diminish net left‐to‐right atrial flow and obscure color Doppler detection on transthoracic echocardiography. The subsequent reduction in PVR to 2.6 Wood units following combination therapy with macitentan and tadalafil coincided with the emergence of an abundant left‐to‐right shunt, thereby “unmasking” the underlying congenital defect. This temporal relationship is persuasive and illustrates the dynamic interplay between pulmonary vascular load, ventricular compliance, and shunt magnitude (Table 1).
TABLE 1.
Hemodynamic factors influencing detection of atrial septal defect in pulmonary arterial hypertension.
| Hemodynamic phase | Pulmonary vascular resistance (PVR) | Right ventricular (RV) compliance | Atrial pressure relationship | Expected interatrial shunt flow | Echocardiographic detectability |
|---|---|---|---|---|---|
| Severe untreated PAH | Markedly elevated | Reduced due to pressure overload | Right‐sided pressures elevated; reduced left‐to‐right gradient | Attenuated or minimal left‐to‐right shunt | May be occult on transthoracic echocardiography |
| Early PAH treatment phase | Decreasing | Gradually improving | Rebalancing of atrial pressure gradients | Increasing left‐to‐right flow | Shunt may become detectable with Doppler or contrast imaging |
| After PAH therapy | Reduced | Improved RV compliance | Restoration of left‐to‐right atrial gradient | Enhanced left‐to‐right shunt flow (“hemodynamic unmasking”) | Increased likelihood of ASD visualization |
| Post‐ASD closure | Low or normalized | Improved remodeling | No interatrial communication | Minimal or absent residual shunt | Confirmation of closure on follow‐up imaging |
Adults with severe pulmonary hypertension are often classified as having idiopathic PAH or PAH associated with systemic or thromboembolic conditions when initial noninvasive imaging fails to identify a structural cardiac lesion. As the authors correctly note, ASD‐related PAH may be clinically indistinguishable from idiopathic PAH when shunt flow is minimal due to markedly elevated right‐sided pressures. This diagnostic overlap has important consequences, as the therapeutic trajectory and long‐term prognosis of congenital heart disease–associated PAH differ substantially from those of true idiopathic disease [3, 4]. The described case reinforces the need for a high index of suspicion for occult intracardiac shunts in adults with precapillary pulmonary hypertension, particularly when right heart catheterization findings suggest shunting despite inconclusive echocardiographic evaluation.
We also find the authors' discussion of RV compliance particularly instructive. In simple secundum ASD, left‐to‐right shunting is primarily driven by the relative compliance of the ventricles and atria rather than by large pressure gradients. Conditions that reduce RV compliance—such as longstanding PAH—can therefore decrease shunt volume or even reverse shunt direction, whereas interventions that improve RV compliance may restore or increase left‐to‐right flow [3]. The reported improvement in the RV stroke volume to RV end‐diastolic pressure ratio after PAH therapy provides indirect support for improved RV diastolic properties and offers a plausible mechanistic explanation for the observed increase in shunt flow. While such indices are not routinely used in clinical practice, their inclusion enriches the physiological narrative of the case and encourages more nuanced interpretation of hemodynamic data in similar contexts.
Importantly, suspicion for an atrial septal defect should not depend exclusively on echocardiographic findings. A comprehensive diagnostic approach begins with careful history taking, physical examination, electrocardiography, and chest radiography, all of which may provide clues suggestive of an underlying left‐to‐right shunt [1, 2]. Characteristic findings such as exertional dyspnea, fixed splitting of the second heart sound, right axis deviation or incomplete right bundle branch block on electrocardiography, and cardiomegaly or prominent pulmonary vasculature on chest radiography should raise clinical suspicion and prompt further investigation. Thus, the diagnosis of ASD should not be considered missed solely because of initially nondiagnostic echocardiographic findings. Although echocardiography remains the first‐line imaging modality for suspected ASD, its sensitivity may be reduced in the presence of elevated right‐sided pressures, significant tricuspid regurgitation, or suboptimal acoustic windows [5, 6]. Accordingly, echocardiography should be viewed as one component of a broader clinical assessment, and persistent suspicion based on clinical and ancillary findings should prompt additional evaluation. As highlighted in existing guidelines and imaging position statements, adjunctive techniques such as agitated saline contrast studies, transesophageal echocardiography, cardiac computed tomography, or cardiovascular magnetic resonance imaging can substantially improve diagnostic yield, particularly when clinical suspicion for shunt disease persists despite nondiagnostic initial studies [3, 5, 7]. The authors appropriately emphasize this point in their key clinical message, and the reported case provides a vivid illustration of why multimodality imaging should be considered early in selected patients with pulmonary hypertension of unclear origin.
In recent years, accumulating evidence has supported the cautious use of targeted PAH therapy to reduce PVR before considering ASD closure in selected patients with severe pulmonary hypertension [4, 8]. By demonstrating normalization of pulmonary hemodynamics and favorable short‐term outcomes following staged medical therapy and device closure, the authors contribute additional real‐world support for this approach. At the same time, the case also serves as a reminder that such strategies require careful patient selection, meticulous hemodynamic reassessment, and close long‐term follow‐up, particularly in light of guideline recommendations that advise against defect closure in patients with persistently elevated PVR despite adequate medical therapy [3, 9].
We would, however, suggest that the phenomenon described in this report may be less novel than it initially appears, although it remains underrecognized in routine clinical practice. Prior case reports and small series have documented the detection of previously unrecognized ASDs following treatment of pulmonary hypertension from various etiologies, including portopulmonary hypertension [10]. These observations collectively suggest that the “unmasking” of shunt lesions after reduction of pulmonary vascular load is a reproducible physiological event rather than an isolated curiosity. Framing this case within this emerging body of literature may help clinicians appreciate that improvement in pulmonary hemodynamics can reveal, rather than create, intracardiac shunts, and that the absence of echocardiographic evidence at baseline does not definitively exclude congenital heart disease in this population.
In conclusion, atrial septal defects may remain clinically and echocardiographically occult in the setting of severe pulmonary arterial hypertension and become hemodynamically apparent following reduction of pulmonary vascular resistance. The emergence of left‐to‐right shunting after targeted PAH therapy underscores the dynamic nature of shunt physiology. Maintaining a high index of suspicion and incorporating multimodality imaging when clinical or hemodynamic findings suggest intracardiac shunting may improve diagnostic accuracy and guide appropriate management.
Author Contributions
Nwachukwu O. Nwachukwu: visualization, writing – review and editing. Chukwuka Elendu: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, visualization, writing – original draft, writing – review and editing. Chimaobi Nwevo: validation, writing – review and editing. Davidson J. Ozoemena: visualization, writing – review and editing. Emmanuel O. Ikechukwu: validation, visualization. Nwamaka C. Bob‐Ume: validation, writing – review and editing. Ebiere S. Kalama: validation, visualization.
Funding
The authors have nothing to report.
Ethics Statement
Ethical approval was not required, as this letter does not involve new patient data, human subject research, or original clinical investigation.
Consent
Written informed consent for publication was obtained by the authors of the original report. This letter does not include new patient data.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
The authors thank the editors and authors of the original report for their valuable contribution to the field.
Data Availability Statement
No datasets were generated or analyzed for this letter.
References
- 1. Fujii T., Yamabe S., Tsuruta Y., et al., “A Case of Atrial Septal Defect Unveiled by the Treatment for Pulmonary Arterial Hypertension,” Clinical Case Reports 14, no. 1 (2025): e71656, 10.1002/ccr3.71656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Brida M., Chessa M., Celermajer D., et al., “Atrial Septal Defect in Adulthood: A New Paradigm for Congenital Heart Disease,” European Heart Journal 43, no. 28 (2022): 2660–2671, 10.1093/eurheartj/ehab646. [DOI] [PubMed] [Google Scholar]
- 3. Baumgartner H., De Backer J., Babu‐Narayan S. V., et al., “2020 ESC Guidelines for the Management of Adult Congenital Heart Disease,” European Heart Journal 42, no. 6 (2021): 563–645, 10.1093/eurheartj/ehaa554. [DOI] [PubMed] [Google Scholar]
- 4. Takaya Y., Akagi T., Sakamoto I., et al., “Efficacy of Treat‐and‐Repair Strategy for Atrial Septal Defect With Pulmonary Arterial Hypertension,” Heart 108, no. 5 (2022): 382–387, 10.1136/heartjnl-2021-319096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Budts W., Miller O., Babu‐Narayan S. V., et al., “Imaging the Adult With Simple Shunt Lesions: Position Paper From the EACVI and the ESC WG on ACHD. Endorsed by AEPC (Association for European Paediatric and Congenital Cardiology),” European Heart Journal Cardiovascular Imaging 22, no. 6 (2021): e58–e70, 10.1093/ehjci/jeaa314. [DOI] [PubMed] [Google Scholar]
- 6. Awasthy N. and Radhakrishnan S., “Stepwise Evaluation of Left to Right Shunts by Echocardiography,” Indian Heart Journal 65, no. 2 (2013): 201–218, 10.1016/j.ihj.2013.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Martin S. S., Shapiro E. P., and Mukherjee M., “Atrial Septal Defects—Clinical Manifestations, Echo Assessment, and Intervention,” Clinical Medicine Insights: Cardiology 8, no. Suppl 1 (2015): 93–98, 10.4137/CMC.S15715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Akagi T., “Current Concept of Transcatheter Closure of Atrial Septal Defect in Adults,” Journal of Cardiology 65, no. 1 (2015): 17–25, 10.1016/j.jjcc.2014.09.002. [DOI] [PubMed] [Google Scholar]
- 9. Akseer S., Horlick E., Vishwanath V., et al., “Prevalence and Outcomes of Pulmonary Hypertension After Percutaneous Closure of Atrial Septal Defect: A Systematic Review and Meta‐Analysis,” European Respiratory Review 29, no. 158 (2020): 200099, 10.1183/16000617.0099-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kubota K., Miyanaga S., Iwatani N., and Ohishi M., “Unknown Atrial Septal Defect Was Diagnosed During the Course of Treatment for Portopulmonary Hypertension: A Case Report,” Journal of Cardiology Cases 26, no. 5 (2022): 383–385, 10.1016/j.jccase.2022.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analyzed for this letter.
